Virtual Biomarkers: An Emerging High-Throughput Research Tool
Thu, Aug 11, 2022 1:00 PM - 2:00 PM EDT
Pathology underlies every facet of healthcare, influencing more than 70% of all medical decisions. Yair Rivenson Ph.D., the CEO and Co-Founder of Pictor Labs, demonstrates how it is possible to alter the centuries old practice of histopathology with a digitized process in a non-destructive fashion. The process is enabled by a machine learning-based virtual staining technology which allows fully digital and virtual multiplex tissue platforms to substantively improve the quality and quantity of pathology samples. He will also discuss additional benefits of the technology.
|
|
|
|